Loading…
Wednesday, June 27 • 10:30am - 11:45am
#335: Collaboration Across the Medical Affairs Ecosystem to Advance Patient Care

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-644-L04-P; CME 1.25; IACET 1.25; RN 1.25

As the healthcare landscape shifts and changes, one thing remains constant – the need for information. Patient groups are increasingly important partners for the pharmaceutical industry. Although our patient community and pharmaceutical industry priorities may be seeking synergistic outcomes, the methods to arrive at these outcomes can often diverge. We share a common goal to help patients, caregivers, and providers understand and manage their disease/condition, including having timely and equitable access to the treatment they need. Patient groups provide the company with an insight on how to support healthcare professionals who in turn support patients. The medical affairs functional area of the industry is often able to contribute a range of skills, scientific and medical expertise, and knowledge which might support these patient advocacy efforts.

This session will shed light on best practices highlighting successful collaborations between patient groups and the medical affairs organizations within the industry.

Learning Objectives

Identify the patient advocacy role in the drug development process; Discuss examples of successful collaborations between patient advocacy groups and medical affairs organizations across the industry; Evaluate ways to foster trust and mutual understanding needed to accomplish successful collaborative efforts between empowered patients.

Chair

Laura Kolaczkowski

Speaker

Panelist
J. Lynn Bass, PharmD

Panelist
Olivier Chateau

Panelist
Upal Basu Roy, PhD, MPH

Panelist
Tanja Keiper, DrSc



Speakers
avatar for J. Lynn Bass

J. Lynn Bass

Senior Director, MSLs & Lead, Global Field Medical Affairs, Rakuten Medical
With 20+ years of experience in Medical Science Liaison and Medical Affairs roles across the pharmaceutical industry, Lynn is currently the Sr. Director, MSLs and Field Medical Affairs at Rakuten Medical, Inc. Her industry career has spanned many therapeutic areas and she has authored... Read More →
OC

Olivier Chateau

Co-Founder, Chief Executive Officer, Health Union, LLC
Olivier’s vision and desire for innovation is a driving force behind HU platforms, services and solutions. During his 10 years in pharma, he gained experience in insight creation, digital technology and analytics which he leverages along with extensive commercial knowledge of the... Read More →
avatar for Tanja Keiper

Tanja Keiper

Director, GCO Clinical Applications & Innovation, Merck KGaA
Tanja Keiper, molecular biologist by training, holds a doctoral thesis in internal medicine and is since 2005 working in the healthcare industry in various positions in R&D. She joined Merck KGaA in 2007 and is since 2014 member of Global Clinical Operations External Innovation/Clinical... Read More →
avatar for Laura Kolaczkowski

Laura Kolaczkowski

Lead Patient Representative, Co-Principal Investigator, iConquerMS PPRN, PCORnet
Laura is an advocate, patient and researcher in multiple sclerosis. She is the co-principal investigator for iConquerMS, a PCORnet Patient Powered Research Network. Experienced in patient centered research, she has been a stakeholder reviewer for PCORI and the DoD CDRMP. A member... Read More →
avatar for Upal Basu Roy

Upal Basu Roy

Director of Translational Research Program/Director of Patient FoRCe, LUNGevity Foundation
As Director of LUNGevity Foundation’s Translational Science Research Program, Upal implements LUNGevity’s research awards program. He is also the Director of Patient FoRCe – LUNGevity Foundation’s patient-focused research center. LUNGevity’s Patient-Focused Research Center... Read More →


Wednesday June 27, 2018 10:30am - 11:45am
Room 257AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA